-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Acetylleucine in Tay-Sachs Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acetylleucine in Tay-Sachs Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acetylleucine in Tay-Sachs Disease Drug Details: Acetylleucine (IB-1001) is under development...
-
Innovation Ranking
Innovation Ranking – Feng Tay Enterprises Co Ltd
Feng Tay Enterprises Co Ltd (Feng Tay) is a manufacturer of shoe products. The company is involved in the research, development and manufacturing of Nike shoes, Converse shoes, casual shoes, athletic equipment, golf balls, and soccer balls. Feng Tay’s corporate structure comprises of human resource planning, technology, and research, shoe model department, holding and finance, supply chain management, logistics management and product design. The company has manufacturing units in China, Indonesia, Vietnam, and India. The company has operating offices in...
-
Innovation Ranking
Innovation Ranking – Chow Tai Fook Jewellery Group Ltd
Chow Tai Fook Jewellery Group Ltd (Chow Tai Fook), a subsidiary of Chow Tai Fook (Holding) Limited designs manufactures and markets jewellery products. The company’s product portfolio includes gem-set jewellery, gold products, platinum/karat gold products and watches. It also offers engagement ring, wedding bands, necklace, pendant, earring, chain/anklet, bracelet and figures. The company markets its products under brands of Hearts on Fire, Monologue, Soinlove and Enzo. Chow Tai Fook also involves in the distribution of watches of various brands. The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nizubaglustat in Tay-Sachs Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nizubaglustat in Tay-Sachs Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nizubaglustat in Tay-Sachs Disease Drug Details: AZ-3102 (nizubaglustat) is under development for...
-
Product Insights
Gia Hung – Hoa Nghiem VINA Industrial Factory – Tay Ninh
The Gia Hung – Hoa Nghiem VINA Industrial Factory – Tay Ninh involves the construction of an industrial complex on 6.5ha of land in Tay Ninh, Vietnam. Equip yourself with the essential tools needed to make informed and profitable decisions with our Gia Hung – Hoa Nghiem VINA Industrial Factory – Tay Ninh report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase,...
-
Product Insights
NewTay-Sachs Disease – Drugs In Development, 2024
Empower your strategies with our Tay-Sachs Disease – Drugs In Development, 2024 report and make more profitable business decisions. Tay-Sachs disease is a rare, inherited metabolic disease that mostly affects young children and involves progressive damage to and death of cells, particularly in the brain. It is caused by a mutation in the enzyme hexosaminidase A, which allows the harmful buildup of lipids (fatty materials such as oils and acids) in cells. Both parents must carry the mutated gene in order...
-
Product Insights
NewProtein O GlcNAcase – Drugs In Development, 2024
The Protein O GlcNAcase pipeline drugs market research report outlays comprehensive information on the Protein O GlcNAcase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Metabolic Disorders, and Genetic Disorders which include indications of Alzheimer's Disease, Parkinson's Disease, Sandhoff Disease (Jatzkewitz-Pilz Syndrome), and Tay-Sachs Disease. It also reviews key players involved in Protein O...
-
Product Insights
NewCeramide Glucosyltransferase – Drugs In Development, 2024
The Ceramide Glucosyltransferase pipeline drugs market research report outlays comprehensive information on the Ceramide Glucosyltransferase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Genetic Disorders, Central Nervous System, and Oncology which include indications of Fabry Disease, Sandhoff Disease (Jatzkewitz-Pilz Syndrome), Tay-Sachs Disease, Polycystic Kidney Disease, Parkinson's Disease, Neuropathy, Solid Tumor, and Bile Duct Cancer (Cholangiocarcinoma)...
-
Product Insights
NewRetinoic Acid Receptor RXR Alpha – Drugs In Development, 2024
The Retinoic Acid Receptor RXR Alpha pipeline drugs market research report outlays comprehensive information on the Retinoic Acid Receptor RXR Alpha targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Dermatology, Central Nervous System, and Genetic Disorders which include indications of Colorectal Cancer, Pancreatic Cancer, Acne Vulgaris, Hand Dermatitis, Alzheimer's Disease, Multiple Sclerosis, Genetic Disorders, and Tay-Sachs...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nizubaglustat in Niemann-Pick Disease Type C
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nizubaglustat in Niemann-Pick Disease Type C report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nizubaglustat in Niemann-Pick Disease Type C Drug Details: AZ-3102...